PORTAGE BIOTECH INC (PRTG) Stock Balance Sheet
NASDAQ:PRTG - Nasdaq - VGG7185A1369 - Common Stock - Currency: USD
| MRQ (2024-6-30) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 3.33M | 5.03M | 10.50M | 23.40M | 2.80M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | 0.00 | |||
| Receivables | 86.00K | 103.00K | 800.00K | 400.00K | 700.00K | |||
| Other Current Assets | 1.78M | 2.56M | 2.30M | 1.10M | 1.50M | |||
| Total Current Assets | 5.20M | 7.70M | 13.70M | 24.80M | 4.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 27.00K | 35.00K | N/A | N/A | N/A | |||
| Investments And Advances | N/A | N/A | 2.90M | 9.10M | 9.10M | |||
| Goodwill | N/A | N/A | 0.00 | 43.30M | 43.30M | |||
| Intangibles | N/A | N/A | 81.70M | 117.40M | 117.40M | |||
| Other Non-Current Assets | 14.00K | 49.00K | 900.00K | 0.00 | 100.00K | |||
| Total Non-Current Assets | 41.00K | 84.00K | 85.40M | 169.90M | 170.00M | |||
| TOTAL ASSETS | 5.24M | 7.78M | 99.10M | 194.70M | 174.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 37.00K | 40.00K | N/A | 0.00 | 200.00K | |||
| Accrued Expenses | 1.31M | N/A | 1.60M | 400.00K | 0.00 | |||
| Accounts Payable | 1.48M | 2.84M | 300.00K | 200.00K | 100.00K | |||
| Other Current Liabilities | 174.00K | 3.00K | 0.00 | 200.00K | 2.90M | |||
| Total Current Liabilities | 3.00M | 2.88M | 1.90M | 800.00K | 3.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 7.00K | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | N/A | N/A | 10.60M | 28.40M | 24.10M | |||
| Other Non-Current Liabilities | 422.00K | 1.56M | 11.30M | N/A | N/A | |||
| Total Non-Current Liabilities | -279.00K | 878.00K | 21.20M | 72.70M | 70.20M | |||
| TOTAL LIABILITIES | 2.73M | 3.76M | 23.10M | 73.50M | 73.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -216.99M | -215.48M | -138.40M | -38.10M | -30.20M | |||
| Minority Interest | -701.00K | -693.00K | -700.00K | 44.20M | 46.20M | |||
| Common Shares | 219.50M | 219.50M | 218.80M | 158.30M | 130.60M | |||
| Other Shareholders' Equity | N/A | N/A | -4.30M | 1.00M | 1.00M | |||
| Shares Outstanding | 1.05M | 989.20K | 17.60M | 13.30M | 12.10M | |||
| Tangible Book Value per Share | 2.39 | 4.07 | -0.32 | -2.97 | -4.90 | |||
| Total Shareholders' Equity | 2.51M | 4.02M | 76.00M | 121.20M | 101.40M | |||
| TOTAL LIABILITIES AND EQUITY | 5.24M | 7.78M | 99.10M | 194.70M | 174.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | 0.00 | N/A | N/A | N/A | |||
| Current Ratio | 1.73 | 2.67 | 7.21 | 31.00 | 1.53 | |||
| Return On Assets (ROA) | -1357.19% | -968.49% | -105.56% | -8.66% | -9.05% | |||
| Return On Equity (ROE) | -2830.59% | -1873.17% | -137.64% | -13.92% | -15.61% | |||
All data in USD , ROIC based on taxRate of 0.21